ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2026
Distress Screening in Parents of Children with Cancer During Active Treatment: A Pilot Study.
Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: A cancer diagnosis during childhood is associated with significant psychological distress in parents. While distress screening is now recognized as a standard of care in pediatric oncology, few programs have effectively implemented this practice-particularly for caregivers of children newly diagnosed with cancer. Objective: In this pilot study, we gathered caregiver distress screening results at two different timepoints (T1 and T2), as part of an initiative to implement systematic distress screening by Oncology Nurse Navigators (ONNs) in a large pediatric oncology centre. Method: Data were analyzed from the Distress Detection Tool (DDT) using a standard quantitative descriptive approach. The DDT includes two validated measures: the Distress Thermometer (DT) with an accompanying Problem List (DT-P) and the Edmonton Symptom Assessment System-Revised (ESAS-r). Results: Fourteen parents agreed to participate and completed assessments at both timepoints, resulting in a total of 28 DDT assessments analyzed. At the time of assessment, parents were approximately 3.6 months post-diagnosis of their child at T1 and 8.3 months at T2. The mean distress score on the DT was 3.5) (SD = 2.35, range = 0-9), with an average of 6.89 problems reported on the Problem List (SD = 4.79, range = 0-18). A total of 42.9% (n = 12) of participants scored above the clinical cut-off of 4 on the DT. Comparison of results between T1 and T2 revealed a decrease in distress scores, with a large to very large effect size (Cohen's d = -1.01). Additionally, there was a 28.5% reduction in the number of parents reporting clinically significant distress. On the ESAS-r, a substantial proportion of parents continued to report clinically significant scores at T2, particularly for fatigue (64.3%, n = 9), drowsiness (57.1%, n = 8), and anxiety (57.1%, n = 8). Conclusion: To our knowledge, this is the first study to examine ESAS-r results and referral rates following distress screening in this population. While distress generally decreases over time, many parents continue to experience significant distress and psychosocial issues. These findings align with previous research and underscore the importance of systematic distress screening to ensure equitable access to care. The DT-P is a practical and effective tool; however, further research is needed before the ESAS-r can be fully integrated as a screening tool for parents of children with cancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.